75
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission

, , , , , , , & show all
Pages 281-290 | Received 11 Jul 2007, Accepted 02 Nov 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hossein Asgarian-Omran, Parvin Forghani, Mohammad Hojjat-Farsangi, Azam Roohi, Ramazan Ali Sharifian, Seyed Mohsen Razavi, Mahmood Jeddi-Tehrani, Hodjatallah Rabbani & Fazel Shokri. (2010) Expression Profile of Galectin-1 and Galectin-3 Molecules in Different Subtypes of Chronic Lymphocytic Leukemia. Cancer Investigation 28:7, pages 717-725.
Read now
Ali Memarian, Mohammad Hojjat-Farsangi, Hossein Asgarian-Omran, Vahid Younesi, Mahmood Jeddi-Tehrani, Ramazan Ali Sharifian, Jalal Khoshnoodi, Seyed Mohsen Razavi, Hodjatallah Rabbani & Fazel Shokri. (2009) Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia. Leukemia & Lymphoma 50:12, pages 2061-2070.
Read now
Mahdi Shabani, Hossein Asgarian-Omran, Parvaneh Vossough, Ramazan A. Sharifian, Mohammad Faranoush, Soheila Ghragozlou, Jalal Khoshnoodi, Azam Roohi, Mahmood Jeddi-Tehrani, Hakan Mellstedt, Hodjatallah Rabbani & Fazel Shokri. (2008) Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leukemia & Lymphoma 49:7, pages 1360-1367.
Read now

Articles from other publishers (7)

Majid Ghayour-Mobarhan, Amir Sadra Zangouei, Seyed Mohammad Hosseinirad, Majid Mojarrad & Meysam Moghbeli. (2020) Genetics of blood malignancies among Iranian population: an overview. Diagnostic Pathology 15:1.
Crossref
Moslem Ahmadi, Fateme Sadri-Ardalani, Mohammad M Amiri, Mahmood Jeddi-Tehrani, Mahdi Shabani & Fazel Shokri. (2018) Immunization with HER2 extracellular subdomain proteins induces cellular response and tumor growth inhibition in mice. Immunotherapy 10:6, pages 511-524.
Crossref
Saeideh Hajizamani, Javad Mohammadi-asl, Amal Saki Malehi, Ahmad Ahmadzadeh, Tina Vosoughi, Mohammad Seghatoleslami & Najmaldin Saki. (2016) Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients?. Comparative Clinical Pathology 25:4, pages 713-720.
Crossref
Ying-zhi He, Zhao Liang, Mei-rong Wu, Qi Wen, Lan Deng, Chao-yang Song, Bing-yi Wu, San-Fang Tu, Rui Huang & Yu-hua Li. (2015) Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia. Leukemia Research 39:6, pages 575-581.
Crossref
Hossein Esfahani, Babak Abdolkarimi & Arash Dehghan. (2012) A Case Report of Simultaneous Occurrence of Wilms Tumor and Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 34:7, pages e308-e309.
Crossref
Antonia Busse, Nicola Gökbuget, Jan Michael Siehl, Dieter Hoelzer, Stefan Schwartz, Anika Rietz, Eckhard Thiel & Ulrich Keilholz. (2009) Wilms’ tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome. Annals of Hematology 88:12, pages 1199-1205.
Crossref
Tohid Kazemi, Hossein Asgarian-Omran, Ali Memarian, Mahdi Shabani, Ramazan A. Sharifian, Parvaneh Vossough, Bita Ansaripour, Hodjatallah Rabbani & Fazel Shokri. (2008) Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunology, Immunotherapy 58:6, pages 989-996.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.